Role of Interventional Radiology in the Treatment of Patients with Neuroendocrine Metastases in the Liver

Management of liver metastasis from neuroendocrine tumors routinely includes an interventional radiologist. Hepatic artery embolization, either bland (transarterial embolization) or with chemotherapy (transarterial chemoembolization), has been shown to improve response rates in neuroendocrine metastases to the liver. Radiofrequency ablation, cryotherapy, and percutaneous alcohol ablation are important adjuncts or alternative treatments to surgical debulking. In this article, the authors examine important techniques in the armamentarium of the interventional radiologist.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: Larry K. Kvols, MD, Neuroendocrine Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612. E-mail: larry.kvols@moffitt.org
  • 1

    MoertelCGJohnsonCMMcKusickMA. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med1994;120:302309.

    • Search Google Scholar
    • Export Citation
  • 2

    CarrascoCHCharnsangavejCAjaniJ. The carcinoid syndrome: palliation by hepatic artery embolization. AJR Am J Roentgenol1986;147:149154.

    • Search Google Scholar
    • Export Citation
  • 3

    AjaniJACarrascoCHCharnsangavejC. Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization. Ann Intern Med1988;108:340344.

    • Search Google Scholar
    • Export Citation
  • 4

    ClarkOHAjaniJABensonAB. NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine Tumors. Version 12008. Available at: www.nccn.org/professionals/physician_gls/PDFneuroendocrine.pdf. Accessed January 3 2009.

    • Search Google Scholar
    • Export Citation
  • 5

    ProyeC. Natural history of liver metastasis of gastroenteropancreatic neuroendocrine tumors: place for chemoembolization. World J Surg2001;25:685688.

    • Search Google Scholar
    • Export Citation
  • 6

    BlonskiWCReddyKRShakedA. Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature. World J Gastroenterol2005;11:76767683.

    • Search Google Scholar
    • Export Citation
  • 7

    SutcliffeRMaguireDRamageJ. Management of neuroendocrine liver metastases. Am J Surg2004;187:3946.

  • 8

    PichlmayrRWeimannAOldhaferKJ. Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma. Eur J Surg Oncol1998;24:6067.

    • Search Google Scholar
    • Export Citation
  • 9

    Le TreutYPDelperoJRDoussetB. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg1997;225:355364.

    • Search Google Scholar
    • Export Citation
  • 10

    VenookAP. Embolization and chemoembolization therapy for neuroendocrine tumors. Curr Opin Oncol1999;11:3841.

  • 11

    StrosbergJRChoiJCantorABKvolsLK. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control2006;13:7278.

    • Search Google Scholar
    • Export Citation
  • 12

    RuszniewskiP. Interventional radiology: less invasive or less effective? In: IrvinMModlinKO eds. A Century of Aadvances in Neuroendocrine Tumor Biology and Treatment. Hanover, Germany: Felsenstein CCCP; 2007.

    • Search Google Scholar
    • Export Citation
  • 13

    DominguezSDenysAMadeiraI. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol2000;12:151157.

    • Search Google Scholar
    • Export Citation
  • 14

    CasadeiRTomassettiPRossiC. Treatment of metastatic glucagonoma to the liver: case report and literature review. Ital J Gastroenterol Hepatol1999;31:308312.

    • Search Google Scholar
    • Export Citation
  • 15

    LeeSMForbesAWilliamsR. Metastatic islet cell tumour with clinical manifestations of insulin and glucagon excess: successful treatment by hepatic artery embolization and chemotherapy. Eur J Surg Oncol1988;14:265268.

    • Search Google Scholar
    • Export Citation
  • 16

    RuszniewskiPRougierPRocheA. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer1993;71:26242630.

    • Search Google Scholar
    • Export Citation
  • 17

    TherasseEBreittmayerFRocheA. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology1993;189:541547.

  • 18

    RocheAGirishBVde BaereT. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol2003;13:136140.

    • Search Google Scholar
    • Export Citation
  • 19

    DiacoDSHajarizadehHMuellerCR. Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization. Am J Surg1995;169:523528.

    • Search Google Scholar
    • Export Citation
  • 20

    ClouseMEPerryLStuartKStokesKR. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion1994;55(Suppl 3):9297.

    • Search Google Scholar
    • Export Citation
  • 21

    StokesKRStuartKClouseME. Hepatic arterial chemoembolization for metastatic endocrine tumors. J Vasc Interv Radiol1993;4:341345.

  • 22

    PerryLJStuartKStokesKRClouseME. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery1994;116:11111116; discussion 1116–1117.

    • Search Google Scholar
    • Export Citation
  • 23

    DiamandidouEAjaniJAYangDJ. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR Am J Roentgenol1998;170:339344.

    • Search Google Scholar
    • Export Citation
  • 24

    DrougasJGAnthonyLBBlairTK. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg1998;175:408412.

    • Search Google Scholar
    • Export Citation
  • 25

    DesaiDCO’DorisioTMSchirmerWJ. Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. Regul Pept2001;96:113117.

    • Search Google Scholar
    • Export Citation
  • 26

    RuszniewskiPMalkaD. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion2000;62(Suppl 1):7983.

    • Search Google Scholar
    • Export Citation
  • 27

    RocheAGirishBVde BaereT. Prognostic factors for chemoembolization in liver metastasis from endocrine tumors. Hepatogastroenterology2004;51:17511756.

    • Search Google Scholar
    • Export Citation
  • 28

    TouziosJGKielyJMPittSC. Neuroendocrine hepatic metastases: does aggressive management improve survival?Ann Surg2005;241:776783; discussion 783–775.

    • Search Google Scholar
    • Export Citation
  • 29

    MarracheFVulliermeMPRoyC. Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours. Br J Cancer2007;96:4955.

    • Search Google Scholar
    • Export Citation
  • 30

    HoASPicusJDarcyMD. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am J Roentgenol2007;188:12011207.

    • Search Google Scholar
    • Export Citation
  • 31

    HajarizadehHIvancevKMuellerCR. Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate. Am J Surg1992;163:479483.

    • Search Google Scholar
    • Export Citation
  • 32

    KimYHAjaniJACarrascoCH. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma. Cancer Invest1999;17:474478.

    • Search Google Scholar
    • Export Citation
  • 33

    GuptaSYaoJCAhrarK. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J2003;9:261267.

    • Search Google Scholar
    • Export Citation
  • 34

    KressOWagnerHJWiedM. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors—a retrospective single-center analysis. Digestion2003;68:94101.

    • Search Google Scholar
    • Export Citation
  • 35

    FiorentiniGRossiSBonechiF. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study. J Chemother2004;16:293297.

    • Search Google Scholar
    • Export Citation
  • 36

    ArtinyanANelsonRSorianoP. Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver. HPB (Oxford)2008;10:396404.

    • Search Google Scholar
    • Export Citation
  • 37

    CarrascoCHChuangVPWallaceS. Apudomas metastatic to the liver: treatment by hepatic artery embolization. Radiology1983;149:7983.

  • 38

    MavligitGMPollockREEvansHLWallaceS. Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer1993;72:375380.

    • Search Google Scholar
    • Export Citation
  • 39

    HanssenLESchrumpfEKolbenstvedtAN. Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report. Acta Oncol1989;28:439443.

    • Search Google Scholar
    • Export Citation
  • 40

    WangbergBWestbergGTylenU. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg1996;20:892899; discussion 899.

    • Search Google Scholar
    • Export Citation
  • 41

    ErikssonBKLarssonEGSkogseidBM. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer1998;83:22932301.

    • Search Google Scholar
    • Export Citation
  • 42

    LoeweCSchindlMCejnaM. Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am J Roentgenol2003;180:13791384.

    • Search Google Scholar
    • Export Citation
  • 43

    RuutiainenATSoulenMCTuiteCM. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol2007;18:847855.

    • Search Google Scholar
    • Export Citation
  • 44

    ChristanteDPommierSGiviBPommierR. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy. Surgery2008;144:885893; discussion 893–884.

    • Search Google Scholar
    • Export Citation
  • 45

    McStayMKMaudgilDWilliamsM. Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy. Radiology2005;237:718726.

    • Search Google Scholar
    • Export Citation
  • 46

    KingJQuinnRGlennDM. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer2008;113:921929.

    • Search Google Scholar
    • Export Citation
  • 47

    KennedyASDezarnWAMcNeillieP. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol2008;31:271279.

    • Search Google Scholar
    • Export Citation
  • 48

    MurthyRKamatPNunezR. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol2008;19:145151.

    • Search Google Scholar
    • Export Citation
  • 49

    RheeTKLewandowskiRJLiuDM. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg2008;247:10291035.

    • Search Google Scholar
    • Export Citation
  • 50

    HellmanPLadjevardiSSkogseidB. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg2002;26:10521056.

    • Search Google Scholar
    • Export Citation
  • 51

    GiovanniniM. Percutaneous alcohol ablation for liver metastasis. Semin Oncol2002;29:192195.

  • 52

    LivraghiTGoldbergSNLazzaroniS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology1999;210:655661.

    • Search Google Scholar
    • Export Citation
  • 53

    LencioniRAAllgaierHPCioniD. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology2003;228:235240.

    • Search Google Scholar
    • Export Citation
  • 54

    AtwellTDCharboneauJWQueFG. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol2005;28:409421.

    • Search Google Scholar
    • Export Citation
  • 55

    ShafirMShapiroRSungM. Cryoablation of unresectable malignant liver tumors. Am J Surg1996;171:2731.

  • 56

    CozziPJEnglundRMorrisDL. Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors. Cancer1995;76:501509.

    • Search Google Scholar
    • Export Citation
  • 57

    SheenAJPostonGJSherlockDJ. Cryotherapeutic ablation of liver tumours. Br J Surg2002;89:13961401.

  • 58

    DuperierTAliAPereiraS. Laparoscopic cryoablation of a metastatic carcinoid tumor. J Laparoendosc Adv Surg Tech A2001;11:105109.

  • 59

    ShapiroRSShafirMSungM. Cryotherapy of metastatic carcinoid tumors. Abdom Imaging1998;23:314317.

  • 60

    VoglTJNaguibNNZangosS. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol2009; in press.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 147 135 6
PDF Downloads 58 57 1
EPUB Downloads 0 0 0